arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Calidi Biotherapeutics, Inc.

CLDI

$1.11 ▼ -0.01 (-0.89%) at close

23 Visible periods

25 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Fair

Bullish

auto_awesome

Analytical Summary

Calidi Biotherapeutics, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $1.6M

Dividend Yield —

Revenue Growth —

Op. Margin —

ROIC -111.3% ↘

FCF / Share $-3.07 ↘

Trailing P/E —

Price / Book 0.7x

FCF Yield —

Debt / Equity 0.19

info Valuation on last close. End-of-day price, Sep 22, 2026.

23-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Net Income Profit after all expenses

$-4.16M

↑ +27.2% —

FCF / Share Free cash flow per share

$-3.07

↓ -669.9% —

Long-Term Debt Long-term obligations

$600.00K

— 0.0% —

trending_up

Bullish Indicators

Debt to EquityDebt to Equity is in the top quartile (lower is better)

warning

Bearish Risks

No bearish risks detected.

Health Breakdown

Financial Health ↓

Cash Quality ↑

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 23, 2021 10-Q ↗	Q4 FY2020 Mar 23, 2021 10-K ↗
EPS Growth YoY (%)	-47.7% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-138.9% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-93.3% Weak → Weak Stable Year-over-year change in earnings per share Optimal: > 10%	-240.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-42.1% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	10.0% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	171.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-364.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	90.2% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	73.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-51.3% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	77.8% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	27.2% Excellent ↑ Excellent Improving Year-over-year change in net income	18.8% Good ↑ Good Improving Year-over-year change in net income	1.0% Caution ↓ Caution Declining Year-over-year change in net income	-1.9% Weak ↓ Weak Declining Year-over-year change in net income	20.9% Good ↓ Good Declining Year-over-year change in net income	29.9% Excellent ↑ Excellent Improving Year-over-year change in net income	50.2% Excellent ↑ Excellent Improving Year-over-year change in net income	21.8% Good ↑ Good Improving Year-over-year change in net income	-11.8% Weak ↓ Weak Declining Year-over-year change in net income	-11.8% Weak ↓ Weak Declining Year-over-year change in net income	-6.1% Weak Weak Year-over-year change in net income	16.5% Good Good Year-over-year change in net income	N/M	N/M	—	-77300.0% Weak Weak Year-over-year change in net income	—	—	—	—	—	—	—
FCF Growth YoY (%)	—	—	—	—	—	—	—	—	—	70.0% Excellent Excellent Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	—	-55.4% Weak Weak Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 2 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 23, 2021 10-Q ↗	Q4 FY2020 Mar 23, 2021 10-K ↗
Effective Tax Rate (%) (%)	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.2% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent ↑ Excellent Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.5% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	-0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—
FCF / Net Income (x)	1.05x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.00x Fair → Fair Stable Free cash flow relative to reported net income Optimal: > 1x	1.24x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	—	1.41x Good Good Free cash flow relative to reported net income Optimal: > 1x	1.32x Good Good Free cash flow relative to reported net income Optimal: > 1x	—	—	0.53x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak → Weak Stable Free cash flow relative to reported net income Optimal: > 1x	—	0.80x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.48x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.50x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.11x Fair Fair Free cash flow relative to reported net income Optimal: > 1x	—	-0.32x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	—	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 23, 2021 10-Q ↗	Q4 FY2020 Mar 23, 2021 10-K ↗
Return on Invested Capital (%)	-111.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-75.7% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-102.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-67.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-239.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-67.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-188.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-220.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	58.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	60.3% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	159.0% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-844.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.3% Good ↓ Good Declining Return earned on debt + equity capital invested Optimal: > 10%	9.8% Fair → Fair Stable Return earned on debt + equity capital invested Optimal: > 10%	9.3% Fair ↑ Fair Improving Return earned on debt + equity capital invested Optimal: > 10%	15.9% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	3.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	3.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	—	5.8% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	112.9% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-57.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.7% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-50.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-36.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-60.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-33.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-28.4% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-78.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-89.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-91.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-98.0% Weak Weak Operating profit relative to total assets Optimal: > 10%	-38.8% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-180.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	—	-0.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-0.2% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	-0.5% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—
Return on Common Equity (%) (%)	-132.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-985%)	-83.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-655%)	-107.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-819%)	-74.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-596%)	—	-72.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-586%)	-267.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1881%)	—	61.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+310%)	49.6% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+231%)	99.9% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+566%)	—	10.1% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-32%)	11.7% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-22%)	15.4% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: At sector avg	17.6% Good ↑ Good Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+17%)	-15.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-11.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	—	0.1% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)	0.0% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-100%)	—	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 23, 2021 10-Q ↗	Q4 FY2020 Mar 23, 2021 10-K ↗
Debt to Equity (x)	0.19x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-68%)	0.12x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-80%)	0.16x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-73%)	0.09x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.34x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-43%)	0.09x Excellent ↓ Excellent Declining Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-86%)	0.39x Good ↑ Good Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-35%)	—	-0.16x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-127%)	-0.23x Excellent ↑ Excellent Improving Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-139%)	-0.25x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-142%)	-1.79x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-398%)	—	—	—	—	—	—	—	—	—	—	—
Interest Coverage (x)	-184.44x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-186.09x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-186.96x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-141.60x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-50.62x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-40.26x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-26.13x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-28.86x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-22.51x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-32.73x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-24.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-21.79x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-27.07x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-46.88x Weak Weak Operating income divided by interest expense Optimal: > 5x	-240.90x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—	—	—	—	—	—
Net Debt (USD)	$600.00K	$600.00K	$600.00K	$600.00K	$600.00K	$600.00K	$600.00K	$473.00K	$1.12M	$2.17M	$2.06M	$1.95M	—	—	—	—	—	—	$-1.06M	$-1.20M	—	$0.00	—
Debt / EBITDA (x)	-0.14x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.14x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.13x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.11x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.12x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.15x Excellent ↑ Excellent Improving Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.46x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.34x Excellent → Excellent Stable Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.51x Excellent ↓ Excellent Declining Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.21x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	-0.27x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—	—	—	—	—	—	—

📊 What does each share earn? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 23, 2021 10-Q ↗	Q4 FY2020 Mar 23, 2021 10-K ↗
Basic EPS, GAAP (USD)	$-2.94	$-0.43	$0.45	$-2.21	$-1.99	$-0.18	$6.70	$-0.65	$-1.40	$-0.20	$2.47	$-0.14	$-14.24	$-0.75	$5.07	$-0.63	—	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-3.07	$-0.40	—	—	—	—	—	—	—	$-0.11	—	—	$-5.89	$-0.36	—	$-1.00	—	—	—	—	—	—	—
Book Value per Share (USD)	$1.50	$0.42	$0.52	$1.00	$0.61	$0.22	$0.89	—	$-1.82	$-0.41	$-2.32	$-0.03	$-72.56	$-6.37	$-5.88	$-5.13	$-0.40	$-0.58	$-0.64	—	—	—	—
Tangible Book Value per Share (USD)	$1.50	$0.42	$0.52	$1.00	$0.61	$0.22	$0.89	—	$-1.82	$-0.41	$-2.32	$-0.03	$-72.56	$-6.37	$-5.88	$-5.13	$-0.40	$-0.58	$-0.64	—	—	—	—
Basic Weighted Avg Shares (shares)	1.42M	10.31M	—	4,907	2,877	27,086	—	7.82M	5.33M	35.55M	—	14.31M	878,000	8.65M	—	8.57M	—	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 23, 2021 10-Q ↗	Q4 FY2020 Mar 23, 2021 10-K ↗
Working Capital (USD)	$2.19M	$3.52M	$2.32M	$5.83M	$696.00K	$6.06M	$731.00K	$-9.36M	$-11.43M	$-13.02M	$-5.93M	$814.00K	—	—	$-42.20M	—	$386.01K	$645.67K	$1.07M	$1.96M	—	—	—
LT Debt (USD)	$600.00K	$600.00K	$600.00K	$600.00K	$600.00K	$600.00K	$600.00K	$2.37M	$1.93M	$3.38M	$2.06M	$1.95M	—	—	—	—	—	—	—	—	—	—	—
Total Equity (USD)	$3.13M	$4.93M	$3.76M	$6.92M	$1.76M	$6.94M	$1.53M	—	$-11.75M	$-14.57M	$-8.23M	$-1.09M	$-63.71M	$-55.10M	$-50.44M	$-43.93M	$-9.24M	$-13.24M	$-14.69M	$-18.98M	$-58.30K	$0.00	$0.00

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 23, 2021 10-Q ↗	Q4 FY2020 Mar 23, 2021 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$0.00	—	—	—	—	—	—	—	—
Depreciation Expense (USD)	—	—	—	—	—	$91.00K	—	$100.00K	$100.00K	$102.00K	$99.00K	$100.00K	$100.00K	$93.00K	$98.00K	$100.00K	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-4.16M	$-4.11M	$-4.06M	$-5.15M	$-5.71M	$-5.06M	$-4.10M	$-5.05M	$-7.22M	$-7.22M	$-8.23M	$-6.46M	$-6.46M	$-6.46M	$-7.76M	$-7.74M	$1.46M	$1.46M	—	$-10.00K	$0.00	—	—
Operating Cash Flow (USD)	$-4.35M	$-4.12M	$-5.04M	$-4.24M	—	$-7.13M	$-5.42M	—	—	$-3.83M	$-5.19M	—	$-5.17M	$-3.11M	$-3.88M	$-8.60M	—	$-465.13K	—	—	$-118.80K	—	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced yesterday 6 years · 23 quarters

Calidi Biotherapeutics, Inc.

Analytical Summary

23-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare CLDI with peers